Robert C Woodworth

Title: The Innovations of Robert C. Woodworth

Introduction

Robert C. Woodworth is an accomplished inventor based in Shelburne, VT (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant transferrins. With a total of 3 patents, his work has implications for medical therapies and research.

Latest Patents

Woodworth's latest patents focus on recombinant transferrins, which include non-glycosylated recombinant transferrin, transferrin half-molecules, and mutant transferrins with altered metal-binding properties. These recombinant transferrin molecules are expressed in functional form by stable eukaryotic cell lines, such as baby hamster kidney cells transformed with an expression vector encoding the recombinant molecule. The applications of these recombinant transferrins are significant, as they can be utilized in metal chelation therapy to bind and eliminate excess toxic metals in patients suffering from metal overloads. Additionally, they can serve as tissue culture medium supplements or replacements.

Career Highlights

Throughout his career, Woodworth has worked with notable institutions, including the University of British Columbia. His research has contributed to advancements in biotechnology and therapeutic applications.

Collaborations

Some of his coworkers include Anne B. Mason and Walter D. Funk, who have collaborated with him on various projects.

Conclusion

Robert C. Woodworth's innovative work in recombinant transferrins showcases his dedication to advancing medical therapies and biotechnology. His contributions continue to impact the field positively.